Stocks to watch, Sept 1: Auto stocks, ITC, Happiest Minds, PVR Inox, Milky Mist, Sun Pharma, TBZ, UltraTech Cement

The domestic stock market is expected to open in the red on Tuesday, September 1. The GIFT NIFTY futures suggest that the NIFTY50 index will open 56 points lower.

Investors will track monthly volumes for clues about demand trends ahead of the festive season, following a strong July, during which major passenger vehicle makers reported robust growth.

As a precursor to the merger, ITC Infotech will acquire a 22.106% stake from Happiest Minds promoter Ashok Soota and Ashok Soota Medical Research LLP, according to regulatory filings.

Following the stake purchase, Happiest Minds will be amalgamated with and into ITC Infotech.

The combined entity, with a global workforce of over 19,000 professionals, will bring complementary capabilities to deliver a full-stack value proposition for end-to-end solutions spanning build, intelligence, and operations whilst expanding into high-potential verticals including hi-tech, healthcare, and edtech.

According to a regulatory filing dated August 31, the company’s board of directors approved the proposal for a buyback of up to 20.69 lakh fully paid-up equity shares, with a face value of ₹1 each, at a price of ₹1,450 apiece.

The dairy products manufacturer reported an 889.91% or nearly a ten-fold year-on-year (YoY) surge in its consolidated net profit to ₹64.68 crore in the April-June quarter of the 2026-27 financial year (Q1 FY27), compared with ₹6.53 crore in the corresponding period of the preceding fiscal year (Q1 FY26).

Its revenue from operations jumped 43.6% YoY to ₹973.45 crore during the quarter under review, as against ₹678.09 crore in the first quarter of the 2025-26 financial year (Q1 FY26), supported by healthy sales performance across the entire product portfolio, reflecting broad-based growth, according to a regulatory filing.

Accordingly, Broadway has ceased to be a wholly-owned subsidiary of the company with effect from August 31, 2026, the pharmaceutical company said in a regulatory filing.

"In continuation of our earlier intimation dated July 11, 2026, we wish to inform you that the company has completed the transaction on August 31, 2026, by transferring its 100% stake held in Broadway Hospitality Services Private Limited to AKRK Projects LLP and its partners," it said.

In its filing to the exchanges on July 11, Mankind Pharma had said the total consideration for the divestment was ₹49 crore, subject to any closing adjustment.

According to the bulk deal data on the BSE, 1575773 Ontario Inc, a Canadian corporate entity, sold 20,92,325 shares, representing a 2% stake in Ahmedabad-based Concord Biotech.

The shares were disposed of at an average price of ₹1,404.10 apiece, taking the transaction value to ₹293.78 crore.

Meanwhile, DSP Mutual Fund (MF) purchased 12.88 lakh shares, amounting to a 1.23% stake in Concord Biotech. The shares were acquired at the same price, taking the deal value to ₹180.86 crore.

After the latest transaction, DSP MF's holding in Concord Biotech has increased to nearly 3% from 1.75%.

As part of its agreement, Sun Pharma will extend Most Favored Nation (MFN) pricing to state Medicaid programs. Sun Pharma also commits to MFN pricing for future innovative medicine launches.

The agreement recognizes Sun Pharma’s investment in the US market by delaying Section 232 tariffs on innovative pharmaceutical products for over two years. Further terms of the agreement remain confidential.

As per the SPA, GRT would acquire the Promoter’s stake for an aggregate value of up to ₹1,033.71 crore. The consummation of the SPA will be subject to appropriate regulatory approvals and customary closing conditions. GRT will also be launching an open offer for another nearly 26% as per applicable SEBI regulations.

With the commissioning of the aforesaid capacity, our capacity under this project stands at 177.6 MWp and ~201 MWh BESS out of the total planned capacity of 232.4 MWp and ~201 MWh BESS.

Pursuant to the commissioning of the above capacity, the aggregate operational capacity of Juniper Green Energy Limited and its subsidiaries stands at ~2,588 MWp and ~500 MWh BESS as of the date hereof.

The acquisition, approved in May for ₹7.6 crore, was to be made from promoter group firm Welspun Corp. However, the two companies mutually decided to cancel the transaction, citing the current demand, supply, and availability of power at the relevant location.